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to 43mm). All patients received follow-up exams with mean follow-up
2.5 years. Bilateral CIA was present in 80% (16/20) of patients. Tech-
nical success was 100% with no procedure related complications. All
aneurysms were treated successfully. The mean implantation time
was 52+24 minutes (range, 35 to 98 minutes). There was no periop-
erative mortality. No internal iliac arteries were lost acutely or
occluded during follow-up. There were no ruptures or conversions in
this cohort group. Two patients required secondary interventions.CONCLUSION This novel sac-ﬁlling technology has made it techni-
cally feasible to preserve hypogastric artery in the setting of common
iliac artery and abdominal aortic aneurysm. High technical success,
simple procedure and low secondary intervention rate are encour-
aging. These advances have the potential to markedly increase the
number of patients treated and diminish complications associated
with conventional management of complex aneurysms.TCTAP A-100
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BACKGROUND Clinical outcome of femoropopliteal (FP) stenting
with drug eluting stents (DES) for diabetic patient remains unclear.
S54 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 5 , N O . 1 7 , S U P P L S , 2 0 1 5The purpose of this study is to investigate the advantage of DES for FP
lesions in diabetic patients.
METHODS This is a single center, retrospective study. Between July
2008 and April 2013, 74 lesions in 58 diabetic patients were treated
with bare metal stents (BMS group).52 lesions in 42 diabetic patients
were treated with Zilver PTX paclitaxel-eluting nitinol stents (DES
group). We evaluate the clinical outcomes as primary patency,
freedom from re-occlusion, major adverse limb events (MALE) and all-
cause death after endovascular therapy. Stent patency was assessed
by either duplex ultrasound or angiography.
RESULTS Mean follow-up period were 616346 days in BMS group
and 372141 days in DES group. Primary patency at a year was 82%
and 87%. (p¼0.96) freedom from re-occlusion at a year were 92% and
91%. (p¼0.29) Freedom from MALE was 94% and 91%. (p¼0.45) Sur-
vival rate were 86% and 95%. (p¼0.18) Multivariate logistic regression
analysis revealed TASC II class C/D increased the risk of restenosis/
reocclusion with an odds ratio [95% conﬁdence interval] of 3.34
[1.30 to 9.03] (p¼0.01)
CONCLUSION Femoropopliteal stenting for diabetic patients with
drug-eluting stent offers no signiﬁcant advantage over bare metal
stent in middle-term clinical outcome.
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BACKGROUND The reentry failure is one of major causes inﬂuencing
the technical success of endovascular treatment of CTOs in iliac and
femoral arteries. This study was conducted to evaluate the success
rate of reentry during endovascular recanalization of iliac and femoral
CTOs and review the alternative treatment after reentry failure in our
institute.
METHODS This is a retrospective study from prospectively registered
database of patients underwent endovascular treatment for long iliac
artery and femoral artery CTO from October 2008 to September 2014
in Seoul St. Mary hospital and Inha university hospital. The patients
treated with acute thrombotic occlusion and hybrid technique were
excluded. We analyzed the baseline characteristics of patients, suc-
cess rate of reentry, and alternative options after reentry failure.
Initial success rate was deﬁned as a success of recanalization with
initial strategy, overall success rate as total success of recanalization
with initial vascular access and/or alternative endovascular treat-
ment(e.g. using CTO device such as Outback, Truepath, Offroad
etc., or distal vessel puncture (Rendezvous or SAFARI technique) after
failure of initial attempt.
RESULTS Fifty seven iliac CTOs (49 patients) and 19 femoral CTOs (18
patients) were enrolled. Initial success rate was 48 (84.2%) and 11
(57.9%) (p¼.026), and overall success of recanalization was 50 (87.7%)
in iliac CTO group and 16 (84.2%) in femoral CTO group (p¼.704). The
lesions which had angiographic stump, the initial success rate was 39
(90.9%), and the lesions those without stump, the initial success rate
was 64.3% in iliac CTOs (p¼.003), and in femoral CTOs were 71.4 vs.
20% (p¼.111), respectively.CONCLUSION In this study the initial success rate was much higher in
iliac CTOs (84.2%) than in femoral CTOs (57.9%) which was
